Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast May 8, 2025 Skin cancer is the most common cancer in the United…
A recent survey surprisingly found only 41% of physicians were “very confident” about their ability…
Originally broadcast April 22, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. announced…
Originally broadcast April 17, 2025 The U.S. healthcare system could save up to 500,000 lives…
Originally broadcast April 10, 2025 Eccentric billionaire Howard Hughes founded his eponymous Medical Institute over…
Originally broadcast April 3, 2025 Roughly 85% of respondents to a survey cited by Michael…